Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 55Completed 38Recruiting 19Not yet recruiting 9Terminated 7Active not recruiting 3Withdrawn 2Suspended 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 2Pancreatic Neoplasms 1Colorectal Neoplasms 1

Interventions

S 1 (combination) 2Oxaliplatin 2Irinotecan 2vactosertib 1titanium silicide 1fludarabine phosphate 1aldesleukin 1Surgical Procedures, Operative 1Receptors, Chimeric Antigen 1Leucovorin 1Interleukin-2 1Infusions, Parenteral 1IL32 protein, human 1Hyperthermic Intraperitoneal Chemotherapy 1Fluorouracil 1Drug Therapy 1Docetaxel 1Cyclophosphamide 1Congresses as Topic 1Capecitabine 1Automobiles 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Stomach Neoplasms × S 1 (combination) × Clear all
NCT00209729 2010-05-26

Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.

Hokkaido Gastrointestinal Cancer Study Group

Phase 1/2 Suspended
50 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00209664 2006-02-02

Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer

Hokkaido Gastrointestinal Cancer Study Group

Phase 2 Suspended
40 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡